Revenue: The sum of all revenue fields included for a company's operating activities.
Amplia Therapeutics Ltd. (INNMF) had Revenue of 3.63M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
3.63M |
-5.10M |
|
-- |
|
3.63M |
|
8.72M |
|
-5.09M |
|
-0.01M |
|
-5.10M |
|
-5.10M |
|
-5.10M |
|
-5.10M |
|
-5.10M |
|
-5.10M |
|
-5.09M |
|
-5.03M |
|
469.65M |
|
469.65M |
|
-0.01 |
|
-0.01 |
|
| Balance Sheet Financials | |
21.86M |
|
0.02M |
|
5.56M |
|
27.42M |
|
1.11M |
|
0.17M |
|
0.20M |
|
1.30M |
|
26.11M |
|
20.86M |
|
26.11M |
|
513.07M |
|
| Cash Flow Statement Financials | |
-5.78M |
|
-0.06M |
|
17.16M |
|
7.19M |
|
18.43M |
|
11.24M |
|
0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.78 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
100.00% |
|
-140.09% |
|
-140.09% |
|
-138.41% |
|
-140.40% |
|
-140.40% |
|
-5.80M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
1.15 |
|
317.72 |
|
-19.53% |
|
-24.44% |
|
-18.60% |
|
-19.40% |
|
0.05 |
|
-0.01 |
|
-0.01 |
|